BlueDot protects people around the world from infectious diseases with data-driven technologies. We help governments protect their citizens, hospitals protect their staff and patients, and businesses protect their employees and customers.
We’ve combined our public health and medical expertise with advanced data analytics to build solutions that track, contextualize, and anticipate infectious disease risks.
SARS spreads from Hong Kong to Toronto, causing an outbreak that cripples the city with 44 deaths and $2 billion in losses.
After completing his training as a physician specializing in infectious diseases and public health in New York City, Dr. Kamran Khan returns to Toronto just before the city’s SARS outbreak begins.
To support growth prospects, BioDiaspora completes a seed round with Horizons Ventures, a private investment of Sir Li Ka-shing, and renames the company to BlueDot – a metaphor for our small world.
Ebola spreads throughout West Africa, with over 11,000 deaths. Using risk models that leverage billions of passenger itineraries, BlueDot predicts the migration of Ebola out of West Africa, publishing its results in The Lancet.
Zika lands in and spreads from Brazil, causing up to $18B in economic damages. This outbreak is also linked to a new symptom: microcephaly in newborns of women infected with Zika virus.
Using our risk assessment models, we predict an outbreak of Zika in Florida, six months before it actually occurred.
[VIDEO] Toronto doctor develops algorithm to track infectious diseases and predict outbreaks
[VIDEO] How can big data help manage infectious diseases?
Join BlueDot in confronting global outbreaks with big data
From chaos to coherence: Managing pandemics with data
How a Toronto company used big data to predict the spread of Zika
Are we ready for the next pandemic?
Only three Ebola-infected travellers per month are likely to fly from West Africa
In New Tools to Combat Epidemics, the Key Is Context
Infectious disease implications of large-scale migration of Venezuelan nationals
International travel between global urban centres vulnerable to yellow fever transmission
Anticipating the international spread of Zika virus from Brazil
Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak
Infectious disease surveillance and modelling across geographic frontiers and scientific specialties
Spread of a Novel Influenza A (H1N1) Virus via Global Airline Transportation